Network Point-of-Care Glucose Testing Market Size Worth USD 2,109.01 Million by 2034 | CAGR: 4.3%

The network point-of-care glucose testing market size is expected to reach USD 2,109.01 million by 2034, according to a new study by Polaris Market Research. The report “Network Point-of-Care Glucose Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Accu-Chek Inform II, StatStrip, HemoCue, BAROzen H Expert Plus, i-STAT, and CareSens Expert Plus), Modality, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Network point-of-care glucose testing refers to a system of connected glucose monitoring devices that enable real-time data sharing between patients and healthcare providers through cloud-based platforms or electronic health records (EHRs). The network point-of-care glucose testing market growth is attributed to the rising prevalence of diabetes, increasing demand for real-time monitoring, and advancements in digital healthcare integration.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/network-point-of-care-glucose-testing-market/request-for-sample

A few key drivers propelling the network point-of-care glucose testing market demand are the rising adoption of continuous glucose monitoring (CGM) systems, technological innovations in wearable and handheld devices, and the need for remote patient management. Opportunities lie in emerging markets where diabetes cases are increasing, alongside the expansion of AI-driven analytics for predictive glucose monitoring. Trends such as noninvasive glucose testing, integration with mobile applications, and regulatory support for digital health solutions further support market expansion.

Network Point-of-Care Glucose Testing Market Report Highlights

• The Accu-Chek Inform II segment, based on product, held the largest network point-of-care glucose testing market share in 2024 due to its widespread adoption in hospitals and clinical settings for accurate and rapid glucose testing.
• North America held the largest share of the network point-of-care glucose testing market revenue in 2024 due to the high prevalence of diabetes, strong healthcare infrastructure, and advanced reimbursement policies.
• Asia Pacific is the fastest-growing region, fueled by rising diabetes cases, increasing healthcare investments, and growing awareness of digital glucose monitoring solutions.
• Several key players in the market are actively contributing to advancements in diabetes management. Abbott Laboratories has developed the FreeStyle Libre system, offering continuous glucose monitoring to patients. F. Hoffmann-La Roche Ltd. provides the Accu-Chek Inform II, a device designed for rapid and accurate blood glucose testing in clinical settings. Nova Biomedical offers the StatStrip Glucose Hospital Meter, known for its precision in point-of-care testing.

Polaris Market Research has segmented the network point-of-care glucose testing market report on the basis of product, modality, and region:

By Product Outlook (Revenue – USD Million, 2020–2034)

• Accu-Chek Inform II
• StatStrip
• HemoCue
• BAROzen H Expert Plus
• i-STAT
• CareSens Expert Plus

By Modality Outlook (Revenue – USD Million, 2020–2034)

• Handheld/Portable Devices
• Wearable Devices
• Benchtop Devices

By Regional Outlook (Revenue – USD Million, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Network Point-Of-Care Glucose Testing Market Report Scope